Interferon-beta and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

Niall Stewart; Steve Simpson; Ingrid van der Mei; Anne-Louise Ponsonby; Leigh Blizzard; Terrence Dwyer; Fotini Pittas; Darryl Eyles; Pauline Ko; Bruce V Taylor

Journal article

Interferon-beta and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

Niall Stewart, Steve Simpson, Ingrid van der Mei, Anne-Louise Ponsonby, Leigh Blizzard, Terrence Dwyer, Fotini Pittas, Darryl Eyles, Pauline Ko, Bruce V Taylor

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2012

DOI: 10.1212/WNL.0b013e31825fded9

University of Melbourne Researchers

Steve Simpson-Yap Author Melbourne School of Population and Global Health

Anne-Louise Ponsonby Author Melbourne School of Population and Global Health

Terry Dwyer Author Paediatrics Royal Children's Hospital

Grants

Awarded by Australian National Health & Medical Research Council

Funding Acknowledgements

The MS Longitudinal Study was funded by a grant from the Australian National Health & Medical Research Council (Project 211308). Additional funding for 25(OH)D measures provided by the Trish Foundation. Additional funding for 1,25(OH)<INF>2</INF>D measures provided by a University of Tasmania Rising Star Award. I.v.d.M. is supported by a Future Fellowship from the Australian Research Council.